Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LL37 in Metastatic Melanoma
NCT02225366Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2015
- Primary completion
- Nov 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ll-37 in melanoma, sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2015; status: completed.
02
Drugs
ll-37
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02225366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225366.